Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000299243

Medchemexpress LLC Ruxolitinib (S enantiomer) | 941685-37-6 | MFCD13184797 | 99.9% | 306.37 | C17H18N6 | 10 MG
SDP

Catalog No. 5000299243
Encompass_Preferred

Ruxolitinib (S enantiomer) is the single S enantiomer of ruxolitinib, an orally active and potent Janus kinase (JAK) inhibitor used in preclinical research to probe JAK-dependent signaling and related disease models. It has demonstrated in vitro suppression of interferon-β-induced gene expression and in vivo activity in myeloproliferative neoplasm models.

  • Orally active, potent JAK inhibitor.
  • Suitable for in vitro and in vivo preclinical studies.
  • Chemical formula C17H18N6, molecular weight 306.37.
  • CAS number 941685-37-6.
  • Reported purity 99.9%.
  • Available as solid and solution formats, including 10 mg solid and 10 mM in DMSO.

Catalog No. 50-002-99243 Supplier Medchemexpress LLC Supplier No. HY50856A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ruxolitinib (S enantiomer) is the single S enantiomer of ruxolitinib, an orally active and potent Janus kinase (JAK) inhibitor used in preclinical research to probe JAK-dependent signaling and related disease models. It has demonstrated in vitro suppression of interferon-β-induced gene expression and in vivo activity in myeloproliferative neoplasm models.

  • Orally active, potent JAK inhibitor.
  • Suitable for in vitro and in vivo preclinical studies.
  • Chemical formula C17H18N6, molecular weight 306.37.
  • CAS number 941685-37-6.
  • Reported purity 99.9%.
  • Available as solid and solution formats, including 10 mg solid and 10 mM in DMSO.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.